Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women during their reproductive ages, associated with a plethora of cardiometabolic consequences, with obesity, insulin resistance and hyperandrogenemia playing a major role in the degree of such manifestations. These consequences include increased risk of glucose intolerance and diabetes mellitus (both type 2 and gestational), atherogenic dyslipidemia, systemic inflammation, non-alcoholic fatty liver disease, hypertension and coagulation disorders.
Source: Metabolism - Clinical and Experimental - Category: Biomedical Science Authors: Panagiotis Anagnostis, Basil C. Tarlatzis, Robert P. Kauffman Tags: Case Report Source Type: research
More News: Alcoholism | Biomedical Science | Cardiology | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Heart | Hypertension | Insulin | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Ovaries | Polycystic Ovary Syndrome | Urology & Nephrology | Women